KWM
ABMD

Kingsview Wealth Management’s Abiomed Inc ABMD Stock Holding History

Kingsview Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-827
Closed -$203K – 918
2022
Q3 		$203K Buy
+827
New +$223K 0.01% 760
2022
Q2 		– Sell
-802
Closed -$266K – 940
2022
Q1 		$266K Hold
802
– – 0.01% 732
2021
Q4 		$288K Hold
802
– – 0.01% 745
2021
Q3 		$261K Hold
802
– – 0.01% 726
2021
Q2 		$251K Buy
802
+153
+24% +$46.9K 0.01% 757
2021
Q1 		$205K Buy
+649
New +$208K 0.01% 769

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kingsview Wealth Management's ABMD Position: Q4 2022 in Review

Kingsview Wealth Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 827 shares — an estimated $203K sold.

Kingsview Wealth Management first reported a position in ABMD in Q1 2021 and held it in 6 quarters. The position peaked at $288K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Kingsview Wealth Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Kingsview Wealth Management sold 827 Abiomed Inc shares in Q4 2022, an estimated $203K.
  • Kingsview Wealth Management first reported a position in Abiomed Inc in Q1 2021 and held it in 6 quarters.
  • Kingsview Wealth Management's Abiomed Inc position peaked at $288K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Kingsview Wealth Management's 13F filing for Q4 2022, filed 13 Feb 2023.